You are on page 1of 6

carbons → alteration of activity and function of

drug
ADRENERGIC AGONIST/ SYMPATHOMIMETICS
- parent drug- origin or precursor of
sympathomimetic drug
- They mimic the effects of neurotransmitters
such as norepinephrine, epinephrine, and
dopamine
- They are adrenergic agonists because they A. Substitutions on the AMINO GROUP
activate the adrenoceptor such as alpha, beta,
and dopaminergic receptors. increasing the size of alkyl substituents on the
amino group 🡪 increases B-receptor activity
Four main receptors - B receptor activity: Isoproterenol- propyl/
- Alpha 1 CH(CH3)2 > epinephrine methyl/ CH(CH3)2 >
- Alpha2 norepinephrine- unsubstituted
- Beta 1 - Norepinephrine is unsubstituted meaning
- Beta 2 walang nasubstitute or nalagay na alkyl group
sa kanyang amine group but nung naging
α1 epinephrine siya, nagkaroon ng methyl
- vasoconstriction 🡪 increase resistance group or CH3 doon sa epinephrine
- increase BP - Isoproterenol- has propyl group in the amino
- closure of bladder sphincter group of phenylethylamine (norepinephrine is
- mydriasis unsubstituted, epinephrine has methyl group,
α2 isoproterenol has propyl group, which has a
greater activity in the beta receptor?
- inhibition of NE (norepinephrine) release
ANSWER; ISOPROTERENOL 🡪 the longer
- inhibit insulin release
β1 the alkyl substituent is, the greater the
- increase heart rate, contractility beta receptor activity. It is more selective
- lipolysis in beta receptor compared to epinephrine and
norepinephrine
- causes positive ino, chrono and
- increase alkyl substituent, increase beta
dromotropic effect
receptor activity
β2
- 4 Substitution- results in alkylation of function or
- bronchodilation
activity of the drug
- uterine relaxation
- glucagon release -> glycogenolysis -> increase
glucose levels
B. Substitutions on the BENZENE RING
ADRENERGIC DRUGS
- stimulate the sympathetic NS Catecholamines
- AKA adrenergic agonist, sympathomimetic, o contain OH at 3, 4 (catechol ring)
adrenomimetic o ex. epinephrine, norepinephrine, isoproterenol,
- they mimic NE and Epinephrine dobutamine, dopamine
- act on one or more receptor sites o Maximal a, B activity (alpha, beta) 🡪 equal
activity of alpha and beta receptor
PHENYLETHYLAMINE o because of presence of OH, rapid inactivation
- Considered as the PARENT compound from by COMT in the intestines so cannot be
which sympathomimetic drugs are derived given orally (given in injections)
- Consists of benzene ring with an ethylamine o COMT- enzyme used to break down
catecholamines
o Can be given through injections
o polar- poor CNS penetration
-
o has catechol ring 🡪 a benzene/catechol ring
- Alpha carbon- nearby amine
which has an OH at carbon 3 and 4
- Beta carbon- nearby benzene
o AKA 1,2 Dihydroxybenzene
- Substitutions may be made on the terminal amino
group, benzene ring, and on the alpha or beta
Non-catecholamines Amphetamine stimulates the release of NE
o absence of one or both OH in 3,4 from the terminal nerve ending.
o ex. phenylephrine, ephedrine, amphetamine 3. Mixed–acting
o longer duration of action since it is not - Affects both the receptor and the release of
inactivated by COMT the neurotransmitter
o can be given orally - Direct and Indirect-Stimulates receptor site
o good CNS penetration 🡪 lipid soluble and release of NE from nerve endings. Ex.
Ephedrine

C. Substitution on the ALPHA CARBON ADRENERGIC AGONISTS

Methylation (adding methyl grp) blocks oxidation by DIRECT ACTING


MAO
- ex. ephedrine, amphetamine 🡪 have methyl group
- Directly bind to the receptor
that blocks the oxidation by MAO so they ay
a. α, β agonists
resistant with the action of MAO.
- Epinephrine, NE, Dopamine
- may promote NE release- indirect-acting
b. α agonists
activity - α1-agonist- Phenylephrine,
- carbon nearby the amino group
Phenylpropanolamine, Methoxamine.
- 2 enzymes responsible for metabolism of - a2-agonist- Clonidine
neurotransmitter in SNS 🡪 MAO and COMT c. β agonists
- β1 agonists- Dobutamine.
- β2 agonists – Salbutamol, Terbutaline.
D. Substitutions on the BETA CARBON - β1 agonists and β2 agonists- Isoproterenol

- addition OH- direct-acting activity Α, Β AGONISTS


1. Epinephrine/ adrenaline
- OH substitute can produce a direct-acting
- DOC: anaphylactic shock 🡪 symptoms: flushing,
activity
bronchoconstriction, redness of skin, hypotension
- Bronchodilator in lungs
- anaphylaxis (bronchodilator)
NOTE:
- treatment for cardiac arrest
- Methylation in alpha carbon causes indirect-acting
activity - local anesthetics 🡪 adjunct drug for local
- Addition of OH group in beta carbon causes anesthetics
direct-acting activity - epinephrine will prevent systemic absorption
of local anesthetic
- eg. lidocaine (1:100,000)- prolongs effect of
local anesthetic
CLASSIFICATION OF ADRENERGIC DRUGS - S/E (side effect): HTN, arrhythmia, MI (myocardial
MOA of sympathomimetic drugs: infarction), pulmonary edema/hemorrhage
According to their effect on organ cells:
1. Direct-acting 2. Norepinephrine (Levophed)/ Noradrenaline
- acts on the receptor such as alpha, beta, and - DOC: septic shock
dopaminergic receptor - Tx. shock/ hypotension
- directly stimulate the adrenergic receptors - increase heart rate, contractility;
(Epinephrine and Norepinephrine) vasoconstriction 🡪 increase BP
2. Indirect-acting - kapag naiinhibit and NE, bumababa and blood
- They will not act on the enzyme pressure
- It will affect the release of the
neurotransmitter 3. Dopamine (Docard)
- Will increase the release of the - DOC: for cardiogenic shock 🡪 congestive heart
neurotransmitter failure, the inability of the heart to pump blood
- Actions are dependent on the release of - a cardiogenic drug
endogenous catecholamine. Example: - tx. shock/ hypotension
- can produce increase in the blood flow and - Causes vasoconstriction and nasal decongestant
cause dilation of renal blood vessel
- renal failure to increase blood flow
- dopamine receptors- dilation of renal vessels OTHER ALPHA 1 AGONISTS
- binds both in dopamine 1 and dopamine 2 receptor 4. Midodrine
- Low dose: dopamine receptors 🡪 may cause - MOA: Activates phospholipase C, resulting in
vasodilation increased intracellular calcium and
- Moderate dose: β-receptors vasoconstriction
- High dose: α-receptors 🡪 may cause - phospholipase C- enzyme converting
vasoconstriction phosphatidylcholine into IP3 and DAG
- Effects: Vascular smooth muscle contraction
Dopamine 1 Agonist: Fenoldopam increasing BP
- effect: peripheral vasodilation in some vascular - Used in the treatment of postural hypotension /
beds. orthostatic hypotension 🡪 common side effect
- for the treatment of severe hypertension (IV) of alpha 1 blocker (a sudden decrease in the blood
- D1 >> D2 (fenoldopam has greater activity in D1 pressure through sudden change of position. Ex.
than in D2 receptor) From lying position to standing position) → ung
- Dopamine 1 Agonist- acts on the vasodilation of nag gagalaxy pag bigla ka tumayo
blood vessel
5. Xylometazoline & oxymetazoline (topical)
Dopamine 2 Agonist: Bromocriptine - When taken in large doses, oxymetazoline may
- MOA: Inhibits adenylyl cyclase and interacts cause hypotension, presumably because of a
with other intracellular pathways central clonidine-like effect
- A decrease in the amount of CAMP that causes - Used for hypotension
vasodilation and bronchoconstriction.
- adenylyl cyclase- converts ATP into CAMP ALPHA 2 AGONISTS
- increase adenylyl cyclase, increase in CAMP 1. Clonidine (Catapres) – SE: rebound hypertension
(causes contraction in heart, bronchodilation (a sudden increase in blood pressure)
in lungs) 2. methyldopa (Aldomet) – a false
- Effects: Mimics dopamine actions in the CNS neurotransmitter (related to dopamine). It gives a
false positive result at coomb’s test (a test for
- Uses: Parkinson’s disease, prolactinemia
hemolytic anemia)
- Parkinson’s disease- depleted yung
3. Guanfacine
dopamine, prolactinemia is an excessive 4. Guanabenz
amount of prolactin causing increase in milk
o treatment of Hypertension 🡪 decrease NE
secretion
release 🡪 decrease BP
- MOA: Inhibits adenylyl cyclase thereby
In pharmacology, iisa lang ang effect ng ex. Alpha 1
agonists, but used in different conditions inhibiting the release of Norepinephrine from
sympathetic nerve endings
- Inhibits release of norepinephrine 🡪 decreases
ALPHA 1 AGONISTS
blood pressure, that is why it is used in the tx. Of
1. Phenylephrine
hypertension
- (Neo-Synephrine, Dimetapp)
- Tx. nasal decongestant, shock, mydriatic
BETA 1 AGONISTS
(dilation of pupil 🡪 treatment of glaucoma)
1. Dobutamine (Dobutrex)
- Causes vasoconstriction
- congestive heart failure
- S/E: HTN 🡪 hypertension
- USED in cardiogenic shock
- S/E: tachycardia, arrhythmia
2. Phenylpropanolamine
- (Neozep, Decolgen, Tuseran, Disudrin, Sinutab),
Pseudoephedrine (Sudafed): nasal decongestant
BETA 2 AGONISTS
- Withdrawn in the US because it causes - Bronchodilation in lungs and relaxation of
hemorrhagic stroke uterus causing tocolytic effect
- Bronchodilator for the treatment of asthma and a
3. Methoxamine tocolytic drug or a drug that prevents premature
- For hypotension (during surgery) induced by labor.
halothane
1. albuterol/ salbutamol (Ventolin)
OTHER SYMPATHOMIMETICS (indirect-acting-
- Terbutaline (Bricanyl), metaproterenol
acts only on release)
- Salmeterol, Formoterol 🡪 bronchodilators
o asthma
2. terbutaline- prevents premature labor acting as 1. Methylphenidate and Pemoline
tocolytic drug – decrease uterine contraction 🡪 - For ADHD
relaxes uterus 2. Modafinil
- S/E: stimulates B1 at high doses: palpitations, - new drug with both similarities to and differences
tremor from amphetamine.
- has significant effects on central 1B receptors but
MIXED BETA 1 AND BETA 2 AGONISTS in addition appears to affect GABAergic,
1. Isoproterenol AKA isoprenaline glutaminergic, and serotonergic synapses
- Has both an activity with b1 and b2 receptor - approved for use in Narcolepsy
- Treatment of cardiac arrest, asthma (rare) (masa-masandal-tulog)
- S/E: Hypertension, palpitations, arrhythmia - it increase norepinephrine release that is why it
- Non-selective beta agonist can be used as a stimulant

INDIRECT ACTING MIXED/ DIRECT AND INDIRECT AGONISTS

promotes NE release - both acting on the receptor and on the release of


- they will not affect the receptor but are neurotransmitter
promoting the norepinephrine release
Ephedrine
1. Tyramine - alkaloid from ma huang (Ephedra sinica)
- rich in tyramine: red wine, beer, cheese, - tx. For urinary incontinence,
chocolates (bawal sa depressed) bronchospasm, hypotension, nasal
- can cause Hypertension in patients taking MAO congestion, narcolepsy
inhibitors (MAO inhibitors are antidepressant - a stimulant and a bronchodilator
drugs) - S/E: HTN, tachycardia, arrhythmia, insomnia
- abundant amount of norepinephrine will cause
hypertensive crisis, cannot be given in patients Metaraminol
taking MAO - Used in tx. Of Hypotension
- MAO: cannot be given in tyramine because - Used to increase blood pressure
tyramine will increase norepinephrine (if taken with - Used when norepinephrine and dopamine is not
maoi) NO POPULAR MEDS possible for the treatment of shock (a
- Nardil (phenelzine) substitute)
- Parnate (tranylcypromine)
- Marplan (isocarboxazid)
ADRENERGIC ANTAGONIST
2. Amphetamines 🡪 increase norepinephrine
release
- For attention deficit hyperactivity disorder - Direct acting- acts on receptor
(ADHD), appetite suppression - Indirect Acting – acts on enzymes or the release
- Used as an appetite suppressant (pag uminom ka of neurotransmitter
nito feeling mo busog ka and hyper ka)
- S/E: HTN, tachycardia, dependence, insomnia,
seizures psychosis
Alpha blockers - Pag madaming CAMP it produces erection
- Alpha 1 receptor will cause vasoconstriction, upon specifically in the penis that it why it can treat
blocking A1, it will cause vasodilation. impotence through penile injection
- Vasodilation, decrease in peripheral vascular - One of the drug for male erectile dysfunction
resistance (PVR), decrease blood pressure
causing hypotension MIXED ALPHA 1 AND ALPHA 2 BLOCKERS
- Postural hypotension- a condition wherein a 1. phenoxybenzamine
sudden change in position will cause a sudden - irreversible, long-acting
drop in blood pressure (causes decrease BP - HTN due to pheochromocytoma 🡪 tumor in the
and dizziness) adrenal medulla
- Compensatory: increase the pulse rate to - (adrenal medulla tumor 🡪 increase epinephrine
produce a reflex tachycardia (para mapataas ng release producing increase in blood pressure)
konti yung blood pressure) - S/E: postural hypotension
- Most common effects of alpha blockers are 2. Phentolamine
orthostatic hypotension (AKA postural - reversible, short-acting
hypotension) causing increased pulse rate to - pheochromocytoma induced HTN
produce reflex tachycardia. - S/E: postural hypotension

BETA BLOCKERS
1. Non Selective blockers
- Blocks both beta 1 and beta 2 receptors causing
decrease in blood pressure and
bronchoconstriction
- Ex. propranolol, timolol, nadolol
- used for HTN, post-MI (myocardial infarction),
angina pectoris, SVT (supra ventricular
ALPHA 1 BLOCKERS 🡪 ends in “osin” tachycardia), heart failure
- Ex. prazosin, doxazosin, terazosin a) Propranolol- tx. Of migraine, stage fright,
- Since alpha 1 agonist causes vasoconstriction, hyperthyroidism. it promotes bradycardia and
alpha 1 blocker causes vasodilation lowers thyroid hormone
- Used in the treatment of Hypertension- decrease - PROTOTYPE DRUG
vasoconstriction - has negative chronotropic and inotropic
- dec. resistance -> dec. BP effect
- tx. For benign prostatic hyperplasia- - used for decreasing heart rate
enlargement of prostate gland that 🡪 prevents - cause decrease in oxygen consumption 🡪 for
urinary retention tx. Of angina
- S/E: orthostatic hypotension especially after the - decrease cardiac output 🡪 decrease blood
first dose of the drug/ syncope pressure
- Syncope- first dose phenomenon 🡪 characterized - contraindicated in px with asthma because it
as fainting at the administration of first dose can cause bronchoconstriction
- To avoid syncope- trim down the dose into 1/3 - tx. Of migraine because it can block the
catecholamine induced vasodilation
or ¼ or the dose to prevent excessive
dropping of blood pressure
b) Timolol
- tx. For glaucoma
ALPHA 2 BLOCKERS
1. Yohimbine - S/E: bradycardia, heart block, bronchospasm
- tx. Of impotence- penile injection in patients with COPD/asthma
- S/E: Bronchoconstriction- contraindicated for
- MOA: used to inhibit PDE 5
asthmatics
(phosphodiesterase) 🡪 an enzyme used for
metabolism of CAMP producing a decrease in
amount of CAMP 2. Selective blockers
- It increases the amount of CAMP producing - Can block beta 1 receptor only 🡪 For the tx. Of
contraction hypertension, not contraindicated in patients with
asthma
- EX. metoprolol, atenolol, esmolol, acebutolol,
nebivolol, BETAXOLOL
- Acronym: BEAAMN- betaxolol, esmolol, atenolol,
acebutolol, metoprolol, nebivolol.
- Most selective beta blocker is nebivolol
- also blocks B2 receptors at high doses

3. Combined/mixed alpha and beta blockers


a) Labetalol 🡪 alternative drug for hydralazine in
the tx. Of pregnancy induced hypertension
b) Carvedilol

4. beta blocker with partial agonist activity


- intrinsic sympathomimetic activity
- ex. Pindolol, acebutolol, labetalol (PAL)
- Cause some bronchodilation
- For treating patients with asthma 🡪 causes
bronchodilation
- A beta 1 blocker but may also produce some
intrinsic sympathomimetic activity. Can be an
agonist at some receptor (a beta 1 blocker
but a beta 2 agonist)

5. beta blocker with MSA (MEMBRANE


STABILIZING ACTIVITY)
- Anesthetic Effect: ex. Pindolol, Propranolol,
Acebutolol, Metoprolol, Labetalol (PAL PM)

INDIRECT ACTING
1. Guanethidine- inhibits release of neurotransmitter,
for tx. Of hypertension
- HTN
- rarely used
2. Reserpine – inhibits VMAT ( a protein responsible
for storage of dopamine in the storage vesicle)
- alkaloid from Rauwolfia serpentina
- tx. For hypertension but is rarely used
- rarely use

RECAP:
Adrenergic
1. direct – acts on receptor
- a1 blocker
- a2 blocker
- mixed alpha 1 and a2 blocker
- beta blocker (5 types)
2. indirect – acts on the release

You might also like